The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and ...

Good day, and welcome to the Stoneridge first-quarter 2025 conference call. (Operator Instructions) Please note this event is being recorded. I would now like to attend the conference over to Kelly ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell ...

Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data, demonstrating potential for a differentiated efficacy and safety profile ...

The Advanced Materials and Manufacturing Program (AMMP) through the nonprofit MTEC SmartZone in Houghton launched its ...

The AI boom in 2025 is driving strong demand for Broadcom's AI infrastructure solutions, making it a compelling buy despite ...

Learn how to create professional diagrams, flowcharts, and organizational charts with this beginner-friendly Microsoft Visio ...

EPS, expectations were $0.03. Operator: Good morning, and welcome to Bausch + Lomb’s First Quarter 2025 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note ...

Additional information, including the accepted abstracts, can be accessed on the ASGCT 28th Annual Meeting website. Presentation materials will be made available in the Science section under ...